ACADIAN ASSET MANAGEMENT LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,025
+3.6%
851,839
-23.4%
0.01%0.0%
Q2 2023$1,954
-37.3%
1,111,372
+9.9%
0.01%
-42.9%
Q1 2023$3,115
+195.0%
1,011,383
+406.8%
0.01%
+180.0%
Q4 2022$1,056
-96.6%
199,564
+1549.4%
0.01%
Q2 2022$31,00012,0990.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders